QQ客服 官方微博 反馈留言

	Effect of phosphodiesterase type 5 inhibitors on prostate cancer risk and biochemical recurrence after prostate cancer treatment: A systematic review and meta-analysis
	Hong, Yang; Wu, Yougen; Qu, Xiaofeng; Wang, Yang; Xia, Ju; Gu, Yuting; Qian, Qingqing
刊名	ANDROLOGIA
	2019
卷号	51期号:2
关键词	biochemical recurrence meta-analysis phosphodiesterase type 5 inhibitors prostate cancer
ISSN号	0303-4569
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3594495
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Hong, Yang,Wu, Yougen,Qu, Xiaofeng,et al. Effect of phosphodiesterase type 5 inhibitors on prostate cancer risk and biochemical recurrence after prostate cancer treatment: A systematic review and meta-analysis[J]. ANDROLOGIA,2019,51(2).
APA	Hong, Yang.,Wu, Yougen.,Qu, Xiaofeng.,Wang, Yang.,Xia, Ju.,...&Qian, Qingqing.(2019).Effect of phosphodiesterase type 5 inhibitors on prostate cancer risk and biochemical recurrence after prostate cancer treatment: A systematic review and meta-analysis.ANDROLOGIA,51(2).
MLA	Hong, Yang,et al."Effect of phosphodiesterase type 5 inhibitors on prostate cancer risk and biochemical recurrence after prostate cancer treatment: A systematic review and meta-analysis".ANDROLOGIA 51.2(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。